Kibdelins, novel glycopeptide antibiotics. I Discovery, production, and biological evaluation.
- 1 January 1986
- journal article
- research article
- Published by Japan Antibiotics Research Association in The Journal of Antibiotics
- Vol. 39 (10) , 1386-1394
- https://doi.org/10.7164/antibiotics.39.1386
Abstract
A new subspecies of Kibdelosporangium aridum subsp. largum (SK&F AAD-609), was isolated and shown to produce novel glycopeptides related to aridicins, but containing a homologous series of glycolipids based on N-acylglucosamine. These compounds showed improvements over the aridicins in in vitro activity and were effective in mouse protection studies against a range of Gram-positive bacteria, including methicillin resistant staphylococci. Pharmacokinetic studies indicated that they have high serum concentrations and long-acting potential. The kibdelin complex modified rumen metabolism in a manner favorable for growth promotion.This publication has 6 references indexed in Scilit:
- Glycopeptide antibiotics: A mechanism-based screen employing a bacterial cell wall receptor mimetic.The Journal of Antibiotics, 1986
- Kibdelins (AAD-609), novel glycopeptide antibiotics. II Isolation, purification and structure.The Journal of Antibiotics, 1986
- Aridicins, novel glycopeptide antibiotics. II. Isolation and characterization.The Journal of Antibiotics, 1985
- Aridicins, novel glycopeptide antibiotics. I. Taxonomy, production and biological activity.The Journal of Antibiotics, 1985
- Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibioticsJournal of Antimicrobial Chemotherapy, 1983
- IDENTIFICATION OF NOCARDIA CAVIAE (ERIKSON) NOV. COMB.*Annals of the New York Academy of Sciences, 1962